imatinib-therapy-of-chronic-myeloid-leukemia-restoImatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell cycle progression27bonebone marrowcellchronic myeloid leukemiaclassgenomehematopoietic systemleukemiamyeloid leukemia2166FalseE-GEOD-33075human2involvement-of-the-tgf-and-catenin-pathways-in-pelInvolvement of the TGF-β and β-catenin pathways in pelvic lymph node metastasis in early stage cervical cancer39cancercarcinomacellcervical cancerclassglycosphingolipidlymphlymph nodepelvic lymph nodesquamoussquamous cellsquamous cell carcinoma3914FalseE-GEOD-26511human3linking-genomic-lesions-with-minimal-residual-diseLinking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia72classdiseasenucleotide2236FalseE-GEOD-39816human1micrornas-are-transported-in-plasma-and-deliveredMicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins (HG-U133 2.0)6classdiseasefamilial hypercholesterolemiahypercholesterolemialipoproteinserum3863FalseE-GEOD-25311human1mll-partner-genes-confer-distinct-biological-and-cMLL partner genes confer distinct biological and clinical signatures of pediatric AML, an AIEOP study42class3526FalseE-GEOD-19577human1peripheral-blood-biomarker-signatures-for-acute-kiPeripheral blood biomarker signatures for acute kidney transplant rejection75classgenomekidneyperipheralureteral obstruction2114FalseE-GEOD-15296human2targeting-the-phosphoinositide-3-kinase-p110-isofoTargeting the Phosphoinositide 3-Kinase p110α Isoform Impairs Cell Proliferation, Survival and Tumor Growth in Small Cell Lung Cancer9cancercellclasslunglung cancerproteinsclc2667FalseE-GEOD-40564human1the-differentially-expressed-genes-induced-by-ev71The differentially expressed genes induced by EV71 infection9aseptic meningitiscellclassencephalomyelitismeningitismyocarditisproteinvirus infection3220FalseE-GEOD-15323human2the-erad-inhibitor-eeyarestatin-i-is-a-bifunctionaThe ERAD inhibitor Eeyarestatin I is a bifunctional compound with an ER localizing domain and a p97/VCP inhibitory group8cancercellclassendoplasmic reticulumlymphomamantle cell lymphomamembranemultiple myelomamyelomaprotein3792FalseE-GEOD-23849human0transcriptional-effects-of-125-dihydroxi-vitamin-dTranscriptional effects of 1,25 dihydroxi-vitamin D3 physiological and supra-physiological concentrations in breast cancer organotypic culture15breastbreast cancercancercellclasshormoneleukocyte3961FalseE-GEOD-27220human3